Sulfobutyl-beta-cyclodextrin sodium, CDE Platform - Pharmaceutical Excipient Registration Number: F20180000620, EU CEP Certification: NO.RO-CEP 2021-025-Rev US FDA DMF Registration Number: 29394, CAS Number: 182410-00-0, Molecular Formula: C42H70-nO35(C4H8SO3Na)n, where n is the degree of substitution, Molecular Weight: 1134+158n.

It is a new type of anionic cyclodextrin derivative with high water solubility, which can form non-covalent complexes with drug by inclusion, thus improving the stability, water solubility, safety of drugs, reducing nephrotoxicity, mitigating the hemolytic nature of drugs, controlling release rate of drugs, covering unpleasant odors, etc. It is now applicable to injectable drugs, oral drugs, nasal drugs, ophthalmic drugs, and has a affinity and inclusion for nitrogen-containing drugs.

Uses: Solubilizer, wetting agent, chelating agent (complexing agent), etc